H.U. Group Research Institute
In July 2017, H.U. Group Research Institute was founded with the aim of consolidating the fundamental research operations within H.U. Group in order to create products and services from novel ideas that will serve as medium- and long-term drivers of growth.
We actively promote open innovation in collaboration with external research organizations, corporate ventures, as well as other industries, primarily in ①innovation in analytics platforms, ②core technologies in medical innovation, and ③utilization of medical information.
In addition, organic collaboration among various businesses within H.U. Group centered around our research institute will allow for efficient development and assessment, which will expedite development that leverages group synergy. In the long run, we endeavor to not only create new business, but new industries through revolutionizing and integrating our technologies and business models.
We aim to become leaders in the life sciences and medical innovation through science.
The two pillars of H.U. Group Research Institute are research and development, and the commercialization of results.
Research & Development in the Life Sciences
We promote innovation in the field of the life sciences with an emphasis on information, technology, and service.
Commercialization of Research Results
We will create new businesses that can serve as future drivers of growth in the life sciences fields.
We are currently engaged in research and development that harnesses cutting-edge microbiome analysis technology for the diagnosis and treatment of diseases.
Technology of H.U.Group Research Institute
we create the medical and health care
for the future
by fusing various technologies.
Using our Exosome/Extracellular
we will reduce
the medical burden
(in diagnosis,treatment, and healthcare)
Using advanced omics technology, we aim to achieve the best medical care for each individual
We will contribute to improving the efficiency and quality of medical care by building "Artificial Intelligence" to support healthcare.
We aim to improve opeations at clinical laboratory by using robots.
We hope to deliver advanced technology to youu hands and contribute to health promotion.
||H.U. Group Research Institute G.K.
||July 3, 2017
||100 million yen
||Kazuya Omi, Ph.D.
||Research and technological development to increase the value and grow the businesses of the H.U. Group
||50 Fuchigami, Akiruno, Tokyo, Japan